GlaxoSmithKline PLC - Asset Resilience Ratio

Latest as of September 2025: 0.02%

GlaxoSmithKline PLC (GSK) has an Asset Resilience Ratio of 0.02% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read total liabilities of GlaxoSmithKline PLC for a breakdown of total debt and financial obligations.

Liquid Assets

GBX10.00 Million

≈ $1.22K USD Cash + Short-term Investments

Total Assets

GBX61.34 Billion

≈ $7.46 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1986–2024)

This chart shows how GlaxoSmithKline PLC's Asset Resilience Ratio has changed over time. See what is GlaxoSmithKline PLC's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down GlaxoSmithKline PLC's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see GlaxoSmithKline PLC (GSK) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	GBX0.00	0%
Short-term Investments	GBX10.00 Million	0.02%
Total Liquid Assets	GBX10.00 Million	0.02%

Asset Resilience Insights

Limited Liquidity: GlaxoSmithKline PLC maintains only 0.02% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

GlaxoSmithKline PLC Industry Peers by Asset Resilience Ratio

Compare GlaxoSmithKline PLC's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Novartis AG SW:NOVN	Drug Manufacturers - General	10.04%
AbbVie Inc NYSE:ABBV	Drug Manufacturers - General	0.02%
Roche Holding AG SW:ROG	Drug Manufacturers - General	15.37%
Zhangzhou Pientzehuang Pharmaceutical Co Ltd SHG:600436	Drug Manufacturers - General	17.40%
AstraZeneca PLC LSE:AZN	Drug Manufacturers - General	0.03%
Shandong Keyuan Pharmaceutical Co. Ltd. A SHE:301281	Drug Manufacturers - General	6.44%
Korean Drug Co. Ltd KQ:014570	Drug Manufacturers - General	12.77%
SANOFI CONS HEALTHC IND L NSE:SANOFICONR	Drug Manufacturers - General	0.07%

Annual Asset Resilience Ratio for GlaxoSmithKline PLC (1986–2024)

The table below shows the annual Asset Resilience Ratio data for GlaxoSmithKline PLC.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.04%	GBX21.00 Million ≈ $2.56K	GBX59.46 Billion ≈ $7.23 Million	-3.77pp
2023-12-31	3.81%	GBX2.25 Billion ≈ $273.27K	GBX59.01 Billion ≈ $7.18 Million	-3.10pp
2022-12-31	6.91%	GBX4.15 Billion ≈ $505.42K	GBX60.15 Billion ≈ $7.32 Million	+6.83pp
2021-12-31	0.08%	GBX61.00 Million ≈ $7.42K	GBX79.10 Billion ≈ $9.62 Million	-0.02pp
2020-12-31	0.10%	GBX78.00 Million ≈ $9.49K	GBX80.43 Billion ≈ $9.79 Million	0.00pp
2019-12-31	0.10%	GBX79.00 Million ≈ $9.61K	GBX79.69 Billion ≈ $9.70 Million	-0.05pp
2018-12-31	0.14%	GBX84.00 Million ≈ $10.22K	GBX58.07 Billion ≈ $7.06 Million	+0.01pp
2017-12-31	0.14%	GBX78.00 Million ≈ $9.49K	GBX56.38 Billion ≈ $6.86 Million	-0.01pp
2016-12-31	0.15%	GBX89.00 Million ≈ $10.83K	GBX59.08 Billion ≈ $7.19 Million	+0.01pp
2015-12-31	0.14%	GBX75.00 Million ≈ $9.13K	GBX53.45 Billion ≈ $6.50 Million	-0.03pp
2014-12-31	0.17%	GBX69.00 Million ≈ $8.40K	GBX40.65 Billion ≈ $4.95 Million	+0.01pp
2013-12-31	0.16%	GBX66.00 Million ≈ $8.03K	GBX42.09 Billion ≈ $5.12 Million	-0.04pp
2012-12-31	0.20%	GBX81.00 Million ≈ $9.86K	GBX41.48 Billion ≈ $5.05 Million	-0.25pp
2011-12-31	0.45%	GBX184.00 Million ≈ $22.39K	GBX41.08 Billion ≈ $5.00 Million	-0.21pp
2010-12-31	0.66%	GBX277.00 Million ≈ $33.70K	GBX42.05 Billion ≈ $5.12 Million	-0.27pp
2009-12-31	0.93%	GBX397.00 Million ≈ $48.30K	GBX42.86 Billion ≈ $5.22 Million	-0.07pp
2008-12-31	0.99%	GBX391.00 Million ≈ $47.57K	GBX39.39 Billion ≈ $4.79 Million	-2.73pp
2007-12-31	3.72%	GBX1.15 Billion ≈ $140.29K	GBX31.00 Billion ≈ $3.77 Million	-0.33pp
2006-12-31	4.05%	GBX1.03 Billion ≈ $125.93K	GBX25.55 Billion ≈ $3.11 Million	+0.28pp
2005-12-31	3.77%	GBX1.02 Billion ≈ $124.71K	GBX27.20 Billion ≈ $3.31 Million	-2.82pp
2004-12-31	6.59%	GBX1.51 Billion ≈ $183.97K	GBX22.94 Billion ≈ $2.79 Million	-5.94pp
2003-12-31	12.53%	GBX2.66 Billion ≈ $323.28K	GBX21.20 Billion ≈ $2.58 Million	+6.19pp
2002-12-31	6.35%	GBX1.42 Billion ≈ $172.41K	GBX22.33 Billion ≈ $2.72 Million	-0.95pp
2001-12-31	7.30%	GBX1.60 Billion ≈ $195.11K	GBX21.97 Billion ≈ $2.67 Million	-3.39pp
2000-12-31	10.69%	GBX2.31 Billion ≈ $280.94K	GBX21.59 Billion ≈ $2.63 Million	-6.08pp
1999-12-31	16.77%	GBX1.75 Billion ≈ $212.80K	GBX10.43 Billion ≈ $1.27 Million	-0.83pp
1998-12-31	17.60%	GBX1.65 Billion ≈ $200.15K	GBX9.35 Billion ≈ $1.14 Million	+0.45pp
1997-12-31	17.15%	GBX1.45 Billion ≈ $176.06K	GBX8.44 Billion ≈ $1.03 Million	+5.11pp
1996-12-31	12.04%	GBX1.00 Billion ≈ $121.79K	GBX8.31 Billion ≈ $1.01 Million	-0.15pp
1995-12-31	12.19%	GBX1.04 Billion ≈ $126.66K	GBX8.54 Billion ≈ $1.04 Million	-22.15pp
1994-06-30	34.33%	GBX2.71 Billion ≈ $329.49K	GBX7.89 Billion ≈ $959.62K	+1.70pp
1993-06-30	32.64%	GBX2.43 Billion ≈ $296.15K	GBX7.46 Billion ≈ $907.42K	+2.28pp
1992-06-30	30.36%	GBX1.73 Billion ≈ $209.88K	GBX5.68 Billion ≈ $691.34K	-6.11pp
1991-06-30	36.47%	GBX2.10 Billion ≈ $254.90K	GBX5.74 Billion ≈ $698.88K	+6.95pp
1990-06-30	29.52%	GBX1.33 Billion ≈ $161.34K	GBX4.49 Billion ≈ $546.55K	+8.79pp
1989-06-30	20.73%	GBX719.00 Million ≈ $87.48K	GBX3.47 Billion ≈ $422.08K	-18.76pp
1988-06-30	39.48%	GBX1.13 Billion ≈ $137.73K	GBX2.87 Billion ≈ $348.83K	+0.81pp
1987-06-30	38.68%	GBX912.00 Million ≈ $110.96K	GBX2.36 Billion ≈ $286.90K	+7.78pp
1986-06-30	30.89%	GBX557.00 Million ≈ $67.77K	GBX1.80 Billion ≈ $219.37K	--

pp = percentage points

About GlaxoSmithKline PLC

LSE:GSK UK Drug Manufacturers - General

Market Cap

$929.05 Million

GBX7.64 Trillion GBX

Market Cap Rank

#9431 Global

#31 in UK

Share Price

GBX1901.00

Change (1 day)

-1.43%

52-Week Range

GBX1344.00 - GBX2268.00

All Time High

GBX2268.00